Wells Fargo analyst Stan Berenshteyn lowered the firm’s price target on Accolade to $10 from $14 and keeps an Equal Weight rating on the shares. While Accolade’s Q2 was fairly uneventful and visibility to 2024 numbers remains good, the firm finds it increasingly difficult to view the company’s long-term guidance as a base case scenario.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACCD:
- Accolade price target lowered to $15 from $17 at Truist
- Accolade price target lowered to $17 from $18 at Canaccord
- Accolade to return to 20% revenue growth amid healthy demand, says Needham
- Accolade price target lowered to $16 from $19 at BofA
- Accolade Announces Results for Fiscal Second Quarter 2024